ASTRO Issued Bladder Cancer Radiation Guidelines
The American Society for Radiation Oncology released new clinical standards for bladder cancer radiation therapy.
Updated on Sept. 18, 2026 in Cancer
Live Poll
Do you trust clinical guidelines to improve health outcomes for patients with cancer?
The American Society for Radiation Oncology (ASTRO) released formal clinical practice guidelines for the use of radiation therapy in treating muscle-invasive bladder cancer. These standards outline appropriate protocols for trimodal therapy and post-surgical care.
Why it matters
These recommendations provide clinicians with a structured framework to improve local disease control and enhance symptom relief for patients. The guidelines help standardize care for those facing complex treatment decisions beyond traditional surgery.
The guidelines address care for the cT2-4aN0M0 muscle-invasive bladder cancer classification, establishing standardized approaches versus previous varied clinical practices. The extent to which these specific protocols will impact universal survival rates remains under investigation.
The players
American Society for Radiation Oncology
This professional organization represents radiation oncologists and promotes the advancement of radiation therapy in cancer treatment.
The details
The new standards recommend trimodal therapy as a viable alternative to radical cystectomy for specific patients, while emphasizing the use of concurrent systemic therapy. For patients post-cystectomy with urothelial carcinoma, the guidelines offer conditional support for adjuvant radiation therapy.
Timeline
Sept. 15, 2026: Guidelines were published online in Practical Radiation Oncology.
Health Landscape
These guidelines extend the care standards previously established by the National Comprehensive Cancer Network bladder cancer clinical guidelines to provide more granular radiation therapy protocols. This integration reflects an ongoing shift toward multimodal cancer management.
Patients may now have access to a standardized trimodal therapy option that potentially avoids radical cystectomy for specific muscle-invasive cancer cases. Individuals should consult with their oncology team to determine if these guidelines align with their specific tumor characteristics.
The takeaway
These updated guidelines emphasize the critical role of intensity-modulated radiation therapy and image guidance in improving local control for bladder cancer patients. Patients are encouraged to discuss these advanced treatment options with their doctors to better understand how current medical standards impact their care plan.
Further reading
Learn more about evolving standards in the Cancer section.
Live Poll
Do you trust clinical guidelines to improve health outcomes for patients with cancer?
